Difference between revisions of "Protamine sulfate (USP)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
m |
||
| Line 12: | Line 12: | ||
*[http://www.uptodate.com/contents/protamine-sulfate-patient-drug-information Protamine sulfate patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/protamine-sulfate-patient-drug-information Protamine sulfate patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/protamine-sulfate-patient-drug-information Protamine sulfate patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/protamine-sulfate-patient-drug-information Protamine sulfate patient drug information (UpToDate)]</ref> | ||
| + | ==Also known as== | ||
| + | *'''Generic name:''' USP | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 23:51, 31 July 2023
General information
Class/mechanism: Heparin antagonist; protamine sulfate is a weak anticoagulant that forms a stable salt with heparin, after which the anticoagulant effect of both drugs is negated.[1][2][3]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
Patient drug information
Also known as
- Generic name: USP